Media Releases
Condensed financial report (PDF 0.5 MB)
Webcast and presentation
Watch the investor webcast
14:00 CET | 13:00 GMT | 08:00 EST
Download the investor presentation (PDF 5.1 MB)
Novartis announces the company’s fourth quarter and 2022 full year financial results.
Feb 01, 2023
Novartis in Society Integrated Report 2022
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders. View the interactive report.
Annual Report 2022
This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also contains our operating and financial results, accompanied by audited annual financial statements.
Social media
In our work to reimagine medicine, we made a real and measurable difference last year in the lives of patients all around the world.
— Vas Narasimhan (@VasNarasimhan) February 1, 2023
I share some highlights and what 2022 meant for @novartis in the video below. https://t.co/rCuqTlc2m5 pic.twitter.com/sggDz7TTxq
Novartis Pipeline
Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.
Executive Committee of Novartis (ECN) biographies
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.
The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.